Clinical Approach to Patients with COVID-19 and Unrecognized Obstructive Sleep Apnea

Purpose: We conducted a retrospective case series of seven male COVID-19 patients with respiratory failure and suspected OSA based on clinical features to evaluate the effects of undiagnosed obstructive sleep apnea (OSA) on COVID-19 outcomes and the response to a continuous positive airway pressure...

Full description

Saved in:
Bibliographic Details
Published in:Clinics and practice 2024-04, Vol.14 (2), p.629-641
Main Authors: Ćurić, Melany, Marinelli, Frano, Prica, Vuk, Pavlović, Marijana, Barković, Igor
Format: Article
Language:English
Subjects:
Body mass index
Continuous positive airway pressure
COVID-19
Hospitals
Hypoxia
Illnesses
Infections
Inflammation
Lungs
obstructive sleep apnea
Oxygen saturation
Oxygen therapy
Patients
Pneumonia
Respiratory diseases
Respiratory failure
SARS-CoV-2
Severe acute respiratory syndrome coronavirus 2
Sleep apnea
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Purpose: We conducted a retrospective case series of seven male COVID-19 patients with respiratory failure and suspected OSA based on clinical features to evaluate the effects of undiagnosed obstructive sleep apnea (OSA) on COVID-19 outcomes and the response to a continuous positive airway pressure (CPAP) treatment. Cardiorespiratory polygraphy (CRP) and a continuous positive airway pressure treatment were used for diagnosis and management. They confirmed severe obstructive sleep apnea in all patients (apnea/hypopnea index > 30) and improved overnight oxygenation and symptoms at the 1-month follow-up. Conclusions: Undiagnosed obstructive sleep apnea may negatively impact COVID-19 outcomes by exacerbating respiratory failure. Recognition and treatment with continuous positive airway pressure can optimize the management of such patients.
ISSN:2039-7283
2039-7275
2039-7283
DOI:10.3390/clinpract14020050